Baseline characteristics associated with the first year treatment interval of intravitreal faricimab in neovascular age-related macular degeneration (nAMD)

Baseline characteristics associated with the first year treatment interval of intravitreal faricimab in neovascular age-related macular degeneration (nAMD)

Aims To identify baseline characteristics that best correlate to treatment interval for naive neovascular age-related macular degeneration patients treated with faricimab in the first year (Y1) of the TENAYA and LUCERNE phase 3 trials, and to further understand how these characteristics may impact t...

Full description

Saved in:
Bibliographic Details
Main Authors: Sobha Sivaprasad, Philippe Margaron, Aachal Kotecha, Thibaud Mathis, Parth Shah, Neala Rafijah, Yannan Tang
Format: Article
Language:English
Published: BMJ Publishing Group 2024-12-01
Series:BMJ Open Ophthalmology
Online Access:https://bmjophth.bmj.com/content/9/1/e001855.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items